Atomistry » Arsenic » PDB 4zt2-5hr7 » 5e29
Atomistry »
  Arsenic »
    PDB 4zt2-5hr7 »
      5e29 »

Arsenic in PDB 5e29: Crystal Structure of Deoxygenated Hemoglobin in Complex with An Allosteric Effector and Nitric Oxide

Protein crystallography data

The structure of Crystal Structure of Deoxygenated Hemoglobin in Complex with An Allosteric Effector and Nitric Oxide, PDB code: 5e29 was solved by M.K.Safo, T.M.Deshpande, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 29.54 / 1.85
Space group P 21 21 2
Cell size a, b, c (Å), α, β, γ (°) 95.878, 98.419, 65.444, 90.00, 90.00, 90.00
R / Rfree (%) 19.8 / 25.3

Other elements in 5e29:

The structure of Crystal Structure of Deoxygenated Hemoglobin in Complex with An Allosteric Effector and Nitric Oxide also contains other interesting chemical elements:

Iron (Fe) 4 atoms

Arsenic Binding Sites:

The binding sites of Arsenic atom in the Crystal Structure of Deoxygenated Hemoglobin in Complex with An Allosteric Effector and Nitric Oxide (pdb code 5e29). This binding sites where shown within 5.0 Angstroms radius around Arsenic atom.
In total only one binding site of Arsenic was determined in the Crystal Structure of Deoxygenated Hemoglobin in Complex with An Allosteric Effector and Nitric Oxide, PDB code: 5e29:

Arsenic binding site 1 out of 1 in 5e29

Go back to Arsenic Binding Sites List in 5e29
Arsenic binding site 1 out of 1 in the Crystal Structure of Deoxygenated Hemoglobin in Complex with An Allosteric Effector and Nitric Oxide


Mono view


Stereo pair view

A full contact list of Arsenic with other atoms in the As binding site number 1 of Crystal Structure of Deoxygenated Hemoglobin in Complex with An Allosteric Effector and Nitric Oxide within 5.0Å range:
probe atom residue distance (Å) B Occ
D:As202

b:0.0
occ:1.00
AS D:CAC202 0.0 0.0 1.0
O2 D:CAC202 1.7 93.7 1.0
O1 D:CAC202 1.7 95.4 1.0
C2 D:CAC202 1.9 93.7 1.0
C1 D:CAC202 1.9 94.3 1.0
O D:HOH310 2.9 52.5 1.0
O D:HOH327 3.2 51.0 1.0
O D:HOH342 3.2 40.6 1.0
O D:HOH391 3.3 59.5 1.0
O D:HOH332 3.5 58.1 1.0
O D:HOH468 3.6 55.6 1.0
O D:HOH318 3.6 54.5 1.0
O D:HOH334 3.7 39.3 1.0
O D:HOH312 3.8 59.8 1.0
O D:HOH365 3.9 60.8 1.0
O D:HOH384 4.0 68.0 1.0
O D:HOH378 4.4 57.3 1.0
O D:HOH533 4.4 58.3 1.0
O B:HOH492 4.6 70.5 1.0
O D:HOH464 4.6 64.0 1.0
O D:HOH479 5.0 60.1 1.0

Reference:

G.G.Xu, T.M.Deshpande, M.S.Ghatge, A.Y.Mehta, A.S.Omar, M.H.Ahmed, J.Venitz, O.Abdulmalik, Y.Zhang, M.K.Safo. Design, Synthesis, and Investigation of Novel Nitric Oxide (No)-Releasing Prodrugs As Drug Candidates For the Treatment of Ischemic Disorders: Insights Into No-Releasing Prodrug Biotransformation and Hemoglobin-No Biochemistry. Biochemistry V. 54 7178 2015.
ISSN: ISSN 0006-2960
PubMed: 26582149
DOI: 10.1021/ACS.BIOCHEM.5B01074
Page generated: Wed Jul 10 12:46:59 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy